FibroBiologics begins patient enrollment for diabetic foot ulcer trial May 5, 2026 08:31AM
Maxim Group Downgrades FibroBiologics (FBLG) to Hold May 4, 2026 08:12AM
FibroBiologics meets NASDAQ listing requirements Apr 20, 2026 04:02PM
FibroBiologics (FBLG) PT Raised to $8 at H.C. Wainwright Apr 16, 2026 10:21AM
FibroBiologics presents thymic organoid data at aging conference Apr 10, 2026 08:32AM


Apr 9, 2026 04:20PM FibroBiologics terminates Texas sublease early, saves $0.8 million
Mar 31, 2026 04:21PM FibroBiologics completes manufacturing of drug for diabetic foot ulcer trial
Mar 26, 2026 07:03AM D. Boral Capital Downgrades FibroBiologics (FBLG) to Hold
Mar 2, 2026 08:30AM FibroBiologics receives US patent for fibroblast osteoporosis therapy
Feb 26, 2026 06:40AM FibroBiologics (FBLG) PT Lowered to $4 at H.C. Wainwright
Feb 23, 2026 08:33AM FibroBiologics receives NASDAQ extension to regain compliance
Feb 6, 2026 04:13PM FibroBiologics faces additional Nasdaq delisting risk over market value
Feb 5, 2026 08:32AM FibroBiologics receives Canadian patent for cachexia treatment
Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
Jan 23, 2026 02:50PM DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event
Jan 7, 2026 08:34AM FibroBiologics CEO outlines 2025 progress in shareholder letter
Jan 5, 2026 08:32AM FibroBiologics reports positive preclinical results for disc therapy
Jan 2, 2026 06:36AM H.C. Wainwright Reiterates Buy Rating on FibroBiologics (FBLG)
Dec 23, 2025 04:04PM FibroBiologics (FBLG) files for 22.94M share offering by selling stockholders
Nov 26, 2025 08:31AM FibroBiologics pays off convertible debt to strengthen balance sheet
Nov 5, 2025 06:07AM FibroBiologics (FBLG) PT Lowered to $5 at H.C. Wainwright
Sep 26, 2025 09:00AM BioVie and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Sep 12, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on FibroBiologics (FBLG)
Sep 11, 2025 08:32AM FibroBiologics reports positive psoriasis treatment study results
Sep 10, 2025 08:30AM FibroBiologics reports progress in bone marrow organoid development
Aug 5, 2025 06:43AM FibroBiologics (FBLG) PT Lowered to $10 at H.C. Wainwright
Jul 28, 2025 08:31AM FibroBiologics files patent for multipotent cell generation methods
Jul 11, 2025 09:00AM Brag House and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Jul 3, 2025 09:00AM Fathom Holdings and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Jun 9, 2025 08:31AM FibroBiologics (FBLG) names Jason Davis as CFO
Apr 8, 2025 08:35AM FibroBiologics (FBLG) opens new Houston lab space
Mar 4, 2025 08:30AM FibroBiologics (FBLG) Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics
Dec 30, 2024 08:32AM FibroBiologics (FBLG) Files for 41.29M Share Offering by Selling Stockhodlers
Dec 23, 2024 07:55AM FibroBiologics (FBLG) Announces $25M Financing
Dec 11, 2024 04:08PM Rodman & Renshaw Starts FibroBiologics (FBLG) at Buy
Nov 19, 2024 09:15AM FibroBiologics (FBLG) Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly
Nov 14, 2024 09:16AM FibroBiologics (FBLG) Files Patent Application Covering Reduction of Blood Clots Associated with IBMIR in Cell-Based Therapeutics
Nov 14, 2024 09:15AM FibroBiologics (FBLG) Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics
Oct 30, 2024 07:55AM H.C. Wainwright Starts FibroBiologics (FBLG) at Buy
Oct 29, 2024 09:16AM FibroBiologics (FBLG) Announces Updates for Novel Artificial Thymus Organoid Technology
Oct 18, 2024 08:31AM FibroBiologics (FBLG) and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases
Oct 16, 2024 09:15AM FibroBiologics (FBLG) Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the EU Patent Office
Sep 4, 2024 07:09AM EF Hutton Starts FibroBiologics (FBLG) at Buy
Aug 20, 2024 09:31AM FibroBiologics (FBLG) Files Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology
Jun 25, 2024 09:31AM FibroBiologics (FBLG) Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
Jun 18, 2024 04:14PM FibroBiologics (FBLG) Announces 16.02M Share Offering by Selling Stockholders